Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79383 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Amlodipine Glucose + Galactose adduct
Formule :C26H35ClN2O10C26H35ClN2O10Masse moléculaire :571.02 : 571.02Oxacillin Related Compound C (5-Methyl-3-phenylisoxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H9NO3Couleur et forme :Off-White PowderMasse moléculaire :203.05824Famciclovir Related Compound E (2-aminopurine)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C5H5N5Couleur et forme :PowderMasse moléculaire :135.0545Abacavir Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :PowderClomipramine Related Compound C (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C19H21ClN2·HClCouleur et forme :Yellow PowderMasse moléculaire :312.13933Brinzolamide Related Compound A ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer))
CAS :Sulfonamides, nesoiFormule :C12H21N3O5S3Couleur et forme :White Off-White PowderMasse moléculaire :383.06433Cetirizine Related Compound B (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H24N2O·2HClCouleur et forme :PowderMasse moléculaire :368.14222Oxaliplatin Related Compound F ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II))
CAS :Inorganic or organic compounds of precious metals, whetFormule :C6H14N2I2PtCouleur et forme :PowderMasse moléculaire :562.88943Phthalic Acid
CAS :Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc not elsewhere specified or includedFormule :C8H6O4Couleur et forme :White PowderMasse moléculaire :166.02661Bisacodyl Related Compound C (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H17NO3Couleur et forme :SolidMasse moléculaire :319.12084Decitabine Related Compound D (Methyl 4-chlorobenzoate)
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C8H7ClO2Couleur et forme :White Yellow PowderMasse moléculaire :170.01346Miconazole Related Compound I (1-{2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole mononitrate)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H15Cl3N2O·HNO3Couleur et forme :White Off-White PowderMasse moléculaire :443.02064Triclocarban Related Compound A (1,3-Bis(4-chlorophenyl)urea)
CAS :Ureines and their derivatives; salts thereofFormule :C13H10Cl2N2OCouleur et forme :White Off-White PowderMasse moléculaire :280.01702Levofloxacin Related Compound E ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H18FN3O4·HClCouleur et forme :Off-White Yellow PowderMasse moléculaire :371.10481Palonosetron Related Compound A ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)
CAS :Lactams not elsewhere specified or includedFormule :C19H24N2O2Couleur et forme :White SolidMasse moléculaire :312.18378Sulfamethoxazole Related Compound B (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C16H16N4O5S2Couleur et forme :Off-White White PowderMasse moléculaire :408.05621Pergolide Sulfoxide ((8β)-8-[(Methylsulfinyl)methyl]-6-propyl-D-ergoline)
CAS :Alkaloids of rye ergot and their derivatives; salts thereof, nesoiFormule :C19H26N2OSCouleur et forme :PowderMasse moléculaire :330.17658Carprofen Related Compound A (Carbazole)
CAS :CarbazoleFormule :C12H9NCouleur et forme :Beige PowderMasse moléculaire :167.07356-Ketonorethindrone Acetate (3,6-Dioxo-19-nor-17α pregn-4-en-20-yn-17-yl acetate)
CAS :Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormule :C22H26O4Couleur et forme :Light Yellow PowderMasse moléculaire :354.18311Fluoroquinolonic Acid
CAS :Compounds (excluding drugs and pesticides) containing aFormule :C13H9ClFNO3Couleur et forme :Beige PowderMasse moléculaire :281.0255Famciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C12H17N5O3Couleur et forme :Off-White PowderMasse moléculaire :279.13314Lomustine Related Compound C (1,3-Dicyclohexylurea)
CAS :Ureines and their derivatives; salts thereofFormule :C13H24N2OCouleur et forme :White PowderMasse moléculaire :224.18886Acetaminophen Related Compound F (p-nitrophenol)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatives of phenols or phenol-alcohols, nesoiFormule :C6H5NO3Couleur et forme :PowderMasse moléculaire :139.02694Triclocarban Related Compound D Mixture (Mixture of 3,5-Bis(4-chlorophenyl)-1-(3,4-dichlorophenyl)biuret and 1,5-Bis(4-chlorophenyl)-3-(3,4-dichlorophenyl)biuret)
Ureines and their derivatives; salts thereofFormule :C20H13Cl4N3O2Couleur et forme :PowderMasse moléculaire :466.97619Amoxicillin Related Compound J (Mixture of amoxicillin and amoxicillin related compound J (amoxicillin open ring dimer))
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Yellow PowderPhenylephrine Related Compound E (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C16H17NO2·HClCouleur et forme :Grey To White PowderMasse moléculaire :291.10261Alclometasone Dipropionate Related Compound A (11β,17,21-Trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C28H38O7Couleur et forme :PowderMasse moléculaire :486.26175Heptamethyl Trisiloxane (1,1,1,3,5,5,5-Heptamethyltrisiloxane)
CAS :Organo-inorganic compounds, nesoiFormule :C7H22O2Si3Couleur et forme :LiquidMasse moléculaire :222.09276Norgestimate Related Compound A (Levonorgestrel acetate)
CAS :Estrogens and progestinsFormule :C23H30O3Couleur et forme :White Off-White PowderMasse moléculaire :354.21949Vigabatrin Related Compound B ((E)-2-(2-aminoethyl)but-2-enoic acid hydrochloride)
Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFormule :C6H11NO2·HClCouleur et forme :White PowderMasse moléculaire :165.05566Chloroquine Related Compound E (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C20H28ClN3O4Couleur et forme :White SolidMasse moléculaire :409.17683Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C15H14N2O3SCouleur et forme :White Fine PowderMasse moléculaire :302.07251Ecamsule Related Compound F (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)
CAS :Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormule :C18H20O6SCouleur et forme :White PowderMasse moléculaire :364.09806Phenylephrine Related Compound D ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C16H19NO2Couleur et forme :White PowderMasse moléculaire :257.14158Uracil
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C4H4N2O2Couleur et forme :White Off-White PowderMasse moléculaire :112.02728Gadoteridol Related Compound C (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C14H24N4O5Couleur et forme :White Light Yellow PowderMasse moléculaire :328.17467Metformin Hydrochloride
CAS :Non-aromatic imines and their derivatives; salts thereof, nesoiFormule :C4H11N5·HClCouleur et forme :White Off-White PowderMasse moléculaire :129.10145Abacavir Stereoisomers Mixture
Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCouleur et forme :White Off-White PowderOrphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride)
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C17H21NO·ClHCouleur et forme :White Off-White PowderMasse moléculaire :291.13899Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Diazepam Related Compound A (2-methylamino-5-chlorobenzophenone)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C14H12ClNOCouleur et forme :Yellow Crystalline PowderMasse moléculaire :245.06074Metaraminol Related Compound B (2-Amino-1-[3-(benzyloxy)phenyl]propan-1-ol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C15H19NO2Couleur et forme :White SolidMasse moléculaire :245.14158Travoprost Related Compound A ((Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-{(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl)hept-5-enoic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their deFormule :C23H29F3O6Couleur et forme :Colorless LiquidMasse moléculaire :458.19162Nevirapine Related Compound A (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C14H14N4OCouleur et forme :Light Yellow Off-White Crystalline PowderMasse moléculaire :254.11676Isomalathion (Diethyl 2-{[methoxy(methylthio)phosphoryl]thio}succinate)
CAS :Organo-sulfur compounds, nesoiFormule :C10H19O6PS2Couleur et forme :Colorless Clear LiquidMasse moléculaire :330.03607Gadoteridol Related Compound B (Gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate dihydrate)
CAS :Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, excluding cerium compounds, nesoiFormule :C14H23GdN4O6·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :501.08587Sulindac Related Compound A ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H17FO3SCouleur et forme :Yellow PowderMasse moléculaire :356.08824Rivaroxaban Related Compound H ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H17Cl2N3O5SCouleur et forme :Yellow PowderMasse moléculaire :469.0266Dronedarone Related Compound C ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone)
CAS :Aromatic pesticides with oxygen heteroFormule :C19H19NO3Couleur et forme :SolidMasse moléculaire :309.13649Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :Off-White SolidMasse moléculaire :195.91526Norscopolamine ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate)
CAS :Aromatic or modified aromatic heterocyclic compounds with nitrogen hetero atom(s) only, except acridine, indole and carbazoleFormule :C16H19NO4Couleur et forme :White Off-White PowderMasse moléculaire :289.13141Chloroquine Related Compound G (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFormule :C18H26ClN3O·H2SO4Couleur et forme :Yellow PowderMasse moléculaire :433.14382Terazosin Related Compound A (6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C14H19N5O2·2HClCouleur et forme :White PowderMasse moléculaire :289.15387Dopamine Related Compound B (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C9H13NO2·HClCouleur et forme :Off-White SolidMasse moléculaire :203.07131Ranolazine Related Compound B (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H31N3O3Couleur et forme :White PowderMasse moléculaire :397.23654Dobutamine Related Compound C (N-(3,4-Dimethoxyphenethyl)-4-(4-methoxyphenyl)butan-2-amine hydrochloride)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C21H29NO3·HClCouleur et forme :White PowderMasse moléculaire :379.19142Ciclopirox Related Compound C (6-Cyclohexyl-4-methylpyridin-2(1H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H17NOCouleur et forme :White Yellow PowderMasse moléculaire :191.13101Ioversol Related Compound B (N,N'-Bis(2,3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2,4,6-triiodoisophthalamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C18H24I3N3O9Couleur et forme :White Off-White GranularMasse moléculaire :806.86467Deferasirox Related Compound F (4-Hydrazinylbenzoic acid)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C7H8N2O2Couleur et forme :Yellow Orange Brown PowderMasse moléculaire :152.05858Cefprozil L-Epimer ((6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19N3O5SCouleur et forme :PowderMasse moléculaire :389.10454Glycopyrrolate Related Compound I ((RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide)
Aromatic or modified aromatic heterocyclic compounds wiFormule :C19H27BrClNO3Couleur et forme :White SolidMasse moléculaire :431.08628Eletriptan S-Enantiomer ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide)
Analgesics, antipyretics and non-hormonal anti-inflammatory agentsFormule :C22H26N2O2S·HBrCouleur et forme :Light Yellow PowderMasse moléculaire :462.09766Imiquimod Related Compound A (1-Isobutyl-1H-imidazo[4,5-c]quinoline)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H15N3Couleur et forme :Light Brown PowderMasse moléculaire :225.1266Flunixin Related Compound B (2-Methyl-3-(trifluoromethyl)aniline)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C8H8F3NCouleur et forme :White Off-White PowderMasse moléculaire :175.06088Leflunomide
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White PowderMasse moléculaire :270.06161Albuterol Related Compound F (4-[2-(tert-Butylamino)-1-ethoxyethyl]-2-(hydroxymethyl)phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C15H25NO3Couleur et forme :White SolidMasse moléculaire :267.18344Thimerosal Related Compound A (2,2'-Disulfanediyldibenzoic acid)
CAS :Other aromatic organoFormule :C14H10O4S2Couleur et forme :PowderMasse moléculaire :306.00205Spironolactone Related Compound A ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C22H28O3Couleur et forme :Light Yellow Crystalline PowderMasse moléculaire :340.20384Granisetron Related Compound C (N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H22N4O·HClCouleur et forme :White PowderMasse moléculaire :298.17936Ketorolac Related Compound C (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H11NO2Couleur et forme :Yellow SolidMasse moléculaire :225.07898Levalbuterol Related Compound A (4-(2-tert-Butylamino-ethyl)-2-hydroxymethyl-phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C13H21NO2Couleur et forme :Off-White PowderMasse moléculaire :223.15723Bumetanide Related Compound A (3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid)
CAS :Sulfonamides, nesoiFormule :C13H12N2O5SCouleur et forme :White Off-White PowderMasse moléculaire :308.04669Orphenadrine Related Compound B (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride)
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormule :C20H28ClNOCouleur et forme :White Off-White PowderMasse moléculaire :333.18594Methoxsalen Related Compound A (4-Methoxy-7H-furo[3,2-g]chromen-7-one)
CAS :Lactones, nesoiFormule :C12H8O4Couleur et forme :White PowderMasse moléculaire :216.04226Fosinopril Related Compound H (4-phenylbutyl phosphonic acid)
CAS :Organo-inorganic compounds, nesoiFormule :C10H15O3PCouleur et forme :White PowderMasse moléculaire :214.07588Azacitidine Related Compound B (1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C28H24O9Couleur et forme :PowderMasse moléculaire :504.14203Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS :Sulfonamides, nesoiFormule :C23H31N7O7SCouleur et forme :White PowderMasse moléculaire :549.20057Etidronate Disodium Related Compound A (Sodium phosphite dibasic pentahydrate)
CAS :Phosphinates (hypophosphites) and phosphonates (phosphiFormule :Na2HPO3·5H20Couleur et forme :White Waxy SolidMasse moléculaire :125.94587Succinylmonocholine Chloride
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, nesoiFormule :C9H18ClNO4Couleur et forme :White PowderMasse moléculaire :239.09244Piroctone Related Compound A ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H32N2O4Couleur et forme :Brown LiquidMasse moléculaire :316.44Memantine Related Compound H (3,5,7-Trimethyladamantan-1-amine hydrochloride)
CAS :Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereofFormule :C13H23N·HClCouleur et forme :White PowderMasse moléculaire :229.15973Trazodone Related Compound D (2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H22BrN5O·HClCouleur et forme :White Crystalline PowderMasse moléculaire :415.10077Prostaglandin A1
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C20H32O4Couleur et forme :White PowderMasse moléculaire :336.23006Methimazole Related Compound A (2,2-Dimethoxy-N-methylethanamine)
CAS :Amino-alcohols, other than those containing more than oneFormule :C5H13NO2Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :119.09463Nimodipine Related Compound B (bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H26N2O8Couleur et forme :Pale Yellow Crystalline PowderMasse moléculaire :434.16892Diazepam Related Compound B (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril)
CAS :Lactams, nesoiFormule :C16H13ClN2OCouleur et forme :Pale Yellow PowderMasse moléculaire :284.07164Cefaclor δ-3 Isomer
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H14ClN3O4SCouleur et forme :Off-White Tan PowderMasse moléculaire :367.03935Dextromethorphan Related Compound C (3-Methoxy-17-methyl-9 α,13 α,14 α-morphinan-10-one)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C18H23NO2Couleur et forme :Light Yellow SolidMasse moléculaire :285.17288Tiotropium Related Compound H ((2RS,3aSR,5RS,6RS,6aRS)-6-Hydroxy-4,4-dimethylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C9H16BrNO2Couleur et forme :White PowderMasse moléculaire :249.03644Ropinirole Related Compound A (4-(2-hydroxyethyl)indolin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C10H11NO2Couleur et forme :Light Yellow PowderMasse moléculaire :177.07898Nicotine Related Compound E ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C10H14N2OCouleur et forme :White Off-White PowderMasse moléculaire :178.11061Eletriptan Related Compound B ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H17BrN2Couleur et forme :Light Yellow PowderMasse moléculaire :292.05751[D-His1]-Exenatide
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C184H282N50O60SCouleur et forme :White CrystalsMasse moléculaire :4184.02731Bosentan Related Compound D (4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C15H10Cl2N4O2Couleur et forme :Yellow PowderMasse moléculaire :349.17Lanolin Alcohols
CAS :Wool grease, except crude, and fatty substances derivedCouleur et forme :Pale Yellow Brownish Yellow Waxy SolidCelecoxib Related Compound C (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C18H16F3N3O2SCouleur et forme :SolidMasse moléculaire :395.09153Famotidine Related Compound E (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C10H14N8S4Couleur et forme :White Beige PowderMasse moléculaire :374.02243Fluoxetine Related Compound C (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C21H22F3NO4Couleur et forme :PowderMasse moléculaire :409.41Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Paclitaxel Related Compound A (Cephalomannine)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C45H53NO14Couleur et forme :White Off-White PowderMasse moléculaire :831.34661Loxapine N-Oxide (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3O2Couleur et forme :White Off-White Pale Yellow SolidMasse moléculaire :343.10875Decitabine Related Compound E (4-Amino-1-(2-deoxy-α-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C8H12N4O4Couleur et forme :White PowderMasse moléculaire :228.08585Lomustine Related Compound B (1-(2-Chloroethyl)-3-cyclohexylurea)
CAS :Compounds with other nitrogen function, nesoiFormule :C9H17ClN2OCouleur et forme :SolidMasse moléculaire :204.10294Azelastine Related Compound D (4-(4-chlorobenzyl)phthalazin-1(2H)-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H11ClN2OCouleur et forme :White PowderMasse moléculaire :270.05599Dronedarone Related Compound B ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride)
CAS :Aromatic pesticides with oxygen heteroFormule :C30H42N2O3·2HClCouleur et forme :SolidMasse moléculaire :550.2729Glycerin
CAS :GlycerolFormule :C3H8O3Couleur et forme :Colorless Clear LiquidMasse moléculaire :92.09 g/molRivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :Pale Yellow SolidMasse moléculaire :453.07613Loxapine Related Compound A (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3OCouleur et forme :Yellow Crystalline PowderMasse moléculaire :327.11384Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101Gadoteridol Related Compound A (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid)
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C17H32N4O7Couleur et forme :White PowderMasse moléculaire :404.2271Proguanil Related Compound E (1-(4-chlorophenyl)-3-cyanoguanidine)
CAS :Nitrile function compounds, not elsewhere specified orFormule :C8H7ClN4Couleur et forme :White Off-White PowderMasse moléculaire :194.03592Nicotine Related Compound B (3-(1-methyl-1H-pyrrol-2-yl)pyridine)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C10H10N2Couleur et forme :Colorless Light Yellow Oily LiquidMasse moléculaire :158.0844Benzalkonium Chloride (5 mL of approx. 4% aqueous solution)
CAS :<p>Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale</p>Couleur et forme :Clear Colorless LiquidIrbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C25H30N6O2Couleur et forme :White PowderMasse moléculaire :446.24302Meclizine Related Compound B (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H27ClN2·2HCl·H2OCouleur et forme :White PowderMasse moléculaire :390.18628Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C23H26N2O5Couleur et forme :White PowderMasse moléculaire :410.18417Gabapentin Related Compound D ([1-(3-Oxo-2-aza-spiro[4.5]dec-2-ylmethyl)cyclohexyl]acetic acid)
CAS :Lactams not elsewhere specified or includedFormule :C18H29NO3Couleur et forme :White PowderMasse moléculaire :307.21474Orlistat Related Compound C (Triphenylphosphine Oxide)
CAS :Non-halogenated organo-phosphorous derivatives, nesoiFormule :C18H15OPCouleur et forme :White Beige PowderMasse moléculaire :278.08605Nevirapine Related Compound B (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C12H10N4OCouleur et forme :Yellow Green PowderMasse moléculaire :226.08546Alprazolam Related Compound A (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H15ClN4OCouleur et forme :White PowderMasse moléculaire :326.093441,2-Dinitroglycerin
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C3H6N2O7Couleur et forme :Clear Colorless LiquidMasse moléculaire :182.0175Cinacalcet Related Compound C ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C22H22F3NHClCouleur et forme :PowderMasse moléculaire :357.17043Aripiprazole Related Compound B (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C13H17NO3Couleur et forme :White PowderMasse moléculaire :235.12084Amantadine Related Compound B (N-(Adamantan-1-yl)acetamide)
CAS :Cyclic amides and their derivatives, nesoiFormule :C12H19NOCouleur et forme :White PowderMasse moléculaire :193.14666Tioconazole Related Compound A (1-[2,4-Dichloro-β-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H14Cl2N2OS·HClCouleur et forme :White Off-White PowderMasse moléculaire :352.02039Tiotropium Related Compound G ((1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide)
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C9H16BrNO2Couleur et forme :White Crystalline PowderMasse moléculaire :249.03644Febuxostat Related Compound D (2-[4-(sec-Butoxy)-3-cyanophenyl]-4-methylthiazole-5-carboxylic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C16H16N2O3SCouleur et forme :Off-White Fine PowderMasse moléculaire :316.08816Benzphetamine Related Compound E ((1S,2S)-2-[Benzyl(methyl)amino]-1-phenylpropan-1-ol hydrochloride)
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C17H21NOHClCouleur et forme :White Off-White PowderMasse moléculaire :255.16231Amantadine Related Compound A (1-Chloroadamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C10H15ClCouleur et forme :White CrystalsMasse moléculaire :170.08623Triamcinolone Acetonide Related Compound C (9-Fluoro-11,21,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11β,16α)-pregna-1,4-diene-3,20-dione)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatives of ketoneFormule :C24H31FO7Couleur et forme :PowderMasse moléculaire :450.20538Dipyridamole Related Compound B (2,2',2'',2''',2'''',2'''''-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H40N8O6Couleur et forme :Green Yellow PowderMasse moléculaire :524.30708Clofazimine Related Compound B (5-(4-Chlorophenyl)-3-(isopropylimino)-N-phenyl-3,5-dihydrophenazin-2-amine)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C27H23ClN4Couleur et forme :Orange Red PowderMasse moléculaire :438.16112Iopromide Related Compound A (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C15H20I3N3O6Couleur et forme :White Crystalline PowderMasse moléculaire :718.84863Indapamide Related Compound A (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
CAS :Sulfonamides, nesoiFormule :C16H14ClN3O3SCouleur et forme :Yellow Brown PowderMasse moléculaire :363.04444Triclosan Related Compounds Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :Colorless Clear LiquidIodixanol Related Compound C (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C33H42I6N6O14Couleur et forme :White Off-White PowderMasse moléculaire :1508.15Lovastatin Epimer Mixture (Epilovastatin and Lovastatin 1:1 Mixture)
Lactones nesoiFormule :C24H36O5Couleur et forme :PowderMasse moléculaire :404.25627Pimobendan Related Compound B (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C19H20N4O3Couleur et forme :White Off-White PowderMasse moléculaire :352.15354Raltegravir Related Compound E (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22N6O5Couleur et forme :White PowderMasse moléculaire :426.16517Cefotaxime Related Compound E ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H13N5O5S2Couleur et forme :Off-White Light Yellow PowderMasse moléculaire :395.03581Xanthanoic Acid
CAS :Aromatic heterocyclic pesticides with oxygen hetero-atom(s) only, nesoiFormule :C14H10O3Couleur et forme :White PowderMasse moléculaire :226.06299Acetaldehyde
CAS :Ethanal (acetaldehyde)Formule :C2H4OCouleur et forme :Clear Colorless LiquidMasse moléculaire :44.02621Losartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C44H43Cl2KN12OCouleur et forme :PowderMasse moléculaire :864.26969Atomoxetine Related Compound B ((R)-N-Methyl-3-phenyl-3-(3-tolyloxy)propan-1-amine hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H21NO·HClCouleur et forme :Off-White Crystalline SolidMasse moléculaire :255.16231Valacyclovir Related Compound C (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C14H22N6O4·HClCouleur et forme :White PowderMasse moléculaire :338.17025Famciclovir Related Compound F (2-Amino-6-chloropurine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C5H4ClN5Couleur et forme :Light Yellow Off-White PowderMasse moléculaire :169.01552Nefazodone Related Compound B (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C25H32ClN5O2·HClCouleur et forme :White PowderMasse moléculaire :506.47Rivaroxaban N-methylphthalamido Analog ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H24N4O6Couleur et forme :White Off-White SolidMasse moléculaire :452.16958Acyclovir Related Compound A (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C10H13N5O4Couleur et forme :White Crystalline PowderMasse moléculaire :267.09675Selegiline Related Compound D ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C12H15N·HClCouleur et forme :White Off-White PowderMasse moléculaire :209.09713Letrozole Related Compound A (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H11N5Couleur et forme :White Off-White PowderMasse moléculaire :285.10145Argatroban
CAS :Sulfonamides used as drugsFormule :C23H36N6O5S·H2OCouleur et forme :White Off-White PowderMasse moléculaire :526.25735Amoxicillin Related Compound G ((2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C24H26N4O7SCouleur et forme :White PowderMasse moléculaire :514.15222Methotrexate Related Compound E (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C15H15N7O2·5HClCouleur et forme :Yellow Tan Orange SolidMasse moléculaire :325.12872Vigabatrin Related Compound A (5-vinylpyrrolidin-2-one)
CAS :Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFormule :C6H9NOCouleur et forme :Clear Colorless Reddish-Brown LiquidMasse moléculaire :111.06841Sodium Picosulfate Related Compound A (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H14NNaO5SCouleur et forme :White PowderMasse moléculaire :379.04904Ropinirole Related Compound B (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride)
CAS :Lactams not elsewhere specified or includedFormule :C16H22N2O2·HClCouleur et forme :Red Brown PowderMasse moléculaire :274.16813Penicillamine Disulfide (3,3'-Dithiodi-D-valine)
CAS :Thioglycolic acid and mercaptocarboxylic acidsFormule :C10H20N2O4S2Couleur et forme :White PowderMasse moléculaire :296.086453-O-Methylmethyldopa
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C11H15NO4·H2OCouleur et forme :White PowderMasse moléculaire :225.10011Moexipril Related Compound F ((S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoic acid)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C15H21NO4Couleur et forme :White PowderMasse moléculaire :279.14706Cetirizine Related Compound A ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H31ClN2O7Couleur et forme :White PowderMasse moléculaire :506.98Captopril Disulfide
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C18H28N2O6S2Couleur et forme :White Solid Crystalline PowderMasse moléculaire :432.13888Acitretin Related Compound A ((2Z,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C21H26O3Couleur et forme :Yellow Crystalline PowderMasse moléculaire :326.18819Frovatriptan Racemate
CAS :Analgesics, antipyretics and non-hormonal anti-inflammaFormule :C14H17N3OMasse moléculaire :243.13716Naphazoline Related Compound A (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H16N2OCouleur et forme :Off-White Yellow SolidMasse moléculaire :228.12626Nebivolol Related Compound A (See USP Certificate for full Chemical Name)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C22H25F2NO4·HClCouleur et forme :PowderMasse moléculaire :441.15184Metaxalone Related Compound A (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H16N2O2Couleur et forme :PowderMasse moléculaire :220.12118Fluorouracil Related Compound F (2-Ethoxy-5-fluoropyrimidin-4(1H)-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H7FN2O2Couleur et forme :White Off-White PowderMasse moléculaire :158.04916Budesonide Related Compound E (16α,17-[butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C25H32O6Couleur et forme :PowderMasse moléculaire :428.21989Doxazosin Related Compound B (6,7-dimethoxyquinazoline-2,4-dione)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C10H10N2O4Couleur et forme :White PowderMasse moléculaire :222.06406Rivastigmine Related Compound E ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C15H25ClN2O2Couleur et forme :White SolidMasse moléculaire :300.16046Formoterol Related Compound D (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :(C20H26N2O4)2·C4H4O4Couleur et forme :Off-White Light Brown SolidMasse moléculaire :832.38947Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS :Lactones, nesoiFormule :C27H40O6Couleur et forme :PowderMasse moléculaire :460.28249Ciclopirox Related Compound B (6-Cyclohexyl-4-methyl-2-pyrone)
CAS :Lactones nesoiFormule :C12H16O2Couleur et forme :Yellow White Crystalline PowderMasse moléculaire :192.26Ranitidine Related Compound A (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate)
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C10H18N2OSC4H4O4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :272.36Trospium Chloride Related Compound C ((1R, 3r, 5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8, 1'-pyrrolidinium]chloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C11H20ClNOCouleur et forme :White SolidMasse moléculaire :217.12334Amoxicillin Related Compound B (L-amoxicillin)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19O5N3SCouleur et forme :PowderMasse moléculaire :365.10454Sotalol Related Compound B (N-(4-Formylphenyl)methanesulfonamide)
CAS :Sulfonamides, nesoiFormule :C8H9NO3SCouleur et forme :Yellow Crystalline PowderMasse moléculaire :199.03031Terazosin Related Compound B (1-(4-Hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H24N4O5Couleur et forme :White PowderMasse moléculaire :388.17467Roflumilast Related Compound B (N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C13H8Cl2F2N2O3Couleur et forme :White PowderMasse moléculaire :347.988Dipyridamole Related Compound F (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C21H36N8O5Couleur et forme :SolidMasse moléculaire :480.28087Rivaroxaban Related Compound J
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C38H36Cl2N6O10S2Couleur et forme :Off-White PowderMasse moléculaire :870.13114Ziprasidone Related Compound F (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H22ClN4NaO2S·H2OCouleur et forme :White Off-White SolidMasse moléculaire :470.11553Clindamycin 2,3-Dipalmitate (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C50H93ClN2O7S·HClCouleur et forme :White Off-White SolidMasse moléculaire :938.27Trandolapril Related Compound A ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C23H32N2O5Couleur et forme :Crystalline PowderMasse moléculaire :416.23112Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H23N3O4HClCouleur et forme :White SolidMasse moléculaire :357.83Tigecycline Related Compound B ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x))
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C23H28N4O7·HClCouleur et forme :Off-White PowderMasse moléculaire :472.1958Latanoprost Related Compound E ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C23H34O5Couleur et forme :Yellow LiquidMasse moléculaire :390.24062Piroxicam Related Compound D (Methyl 2-[1,1-dioxido-3-oxobenzoisothiazol-2(3H)-yl]acetate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H9NO5SCouleur et forme :White SolidMasse moléculaire :255.02014Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C20H24ClN3S·2HClCouleur et forme :Light Grey PowderMasse moléculaire :373.13795Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C32H43NO6Couleur et forme :Light Grey Blue PowderMasse moléculaire :537.30904Spironolactone Epimer Mixture (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture)
Lactones nesoiCouleur et forme :SolidN-Ethylpiperazine
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C6H14N2Couleur et forme :Colorless LiquidMasse moléculaire :114.1157R-Omeprazole (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O3SCouleur et forme :White PowderMasse moléculaire :345.11471Benzhydrol
CAS :Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C13H12OCouleur et forme :White Off-White PowderMasse moléculaire :184.08882Indole
CAS :Acridine (10-azaanthracene) and indole (2,3-benzopyrrole)Formule :C8H7NCouleur et forme :White Crystalline PowderMasse moléculaire :117.05785Dipyridamole Related Compound C (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C20H30ClN7O2Couleur et forme :Light Yellow SolidMasse moléculaire :435.21495Zaleplon Related Compound C (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C17H17N5O2Couleur et forme :PowderMasse moléculaire :323.13822
![Orphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1479031.webp&w=3840&q=75)
![Famotidine Related Compound E (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguan…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1269254.webp&w=3840&q=75)
amino}benzoic acid, …](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1414058.webp&w=3840&q=75)
![Ropinirole Related Compound B (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1605227.webp&w=3840&q=75)
